Women in Cancer Immunotherapy Network

Aug. 19–20, 2019 • Seattle, Wash.

ORGANIZERS:
Lisa H. Butterfield, PhD – Parker Institute for Cancer Immunotherapy/University of California San Francisco
Mary L. Disis, MD, FACP – University of Washington
Olivera J. Finn, PhD – University of Pittsburgh
Kristin Hege, MD – Celgene Corporation/University of California San Francisco
Elizabeth M. Jaffee, MD – Sidney Kimmel Cancer Center – Jefferson Health
Solange Peters, MD, PhD – Centre Hospitalier Universitaire Vaudois
Padmanee Sharma, MD, PhD – The University of Texas MD Anderson Cancer Center

The Women in Cancer Immunotherapy Network (WIN) is a Society for Immunotherapy of Cancer initiative seeking to promote and elevate women in the cancer immunotherapy field. An initiative championed by SITC Immediate Past President Lisa H. Butterfield, PhD, the society's first female president, the network includes programs that provide a forum for women to discuss important topics relevant to their advancement in the field.

The SITC Women in Cancer Immunotherapy Network (WIN) Leadership Institute, scheduled for Aug. 19–20, 2019, in Seattle, is a free, one-and-a-half day program organized by female luminaries in the cancer immunotherapy field that seeks to empower emerging female leaders in the field.

The institute will explore topics relevant to women, including:

• Learn to break through the glass ceiling
• Explore negotiation techniques
• Master the art of saying no
• How to survive in a political world
• Develop leadership skills, including conflict resolution strategies and public speaking

The WIN Leadership Institute (view schedule here) will feature presentations from experienced female leaders, panel discussions allowing participants to ask questions and interact with these leaders and informal networking opportunities throughout the program.

The application process is now closed.

Thank you for applying for the Women in Cancer Immunotherapy Network (WIN) Leadership Institute.

Applicants will be notified by the end of June.

The WIN Leadership Institute is supported in part by grants from Bristol-Myers Squibb, Incyte Corporation, and Merck & Co., Inc.

Available to SITC members, the WIN is creating a database that can be used to better identify female experts to engage in society activities.

The network is seeking women interested in presenting data, speaking at meetings, serving as subject matter experts, conducting article reviews for the Journal for ImmunoTherapy of Cancer (JITC), serving as meeting chairs, co-chairs, organizers, and more. Female SITC members are asked to sign up for this opportunity via the SITC Volunteer Pool to indicate your interest and be included in this database. SITC will use this information to better ensure balanced representation in all society activities. Please join now to be a part of this exciting effort within the society.

If you have questions about the database, please contact Senior Administrative Manager, Rosanne Stelpflug.

SITC Professional Interest Communities are an original series of online communities created exclusively for SITC members. Within these communities, researchers and clinicians in the cancer immunotherapy field expand their network and receive career development support from colleagues.

The Women in SITC Community is open to women who share a common interest in immunology and cancer. Open to professional women, the goal of the community is to increase females in leadership roles within the society, foster connections and working opportunities among members, discuss immunotherapy toxicities (open to other specialties that deal with toxicity of immunotherapy), create mentorship opportunities, discuss gender bias and professional opportunities and contributions to the field of oncology/immunotherapy.

Not a member? Join SITC today and gain immediate access to the Women in SITC Community!

On Friday, Nov. 9, 2018, SITC hosted its second-annual Women in Cancer Immunotherapy Reception.

Held during the society's 33^rd Annual Meeting & Pre-Conference Programs (SITC 2018), the event was a continuation of an effort by the society to connect female professionals in the cancer immunotherapy field to network and discuss important issues they are facing.